Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...
Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and ...
Palvelussamme on juuri nyt häiriö, yritäthän myöhemmin uudelleen. Pahoittelemme aiheutunutta haittaa.
Delving into the opportunities for PE firms – including Diversis, GHO, InTandem and Summit Partners – to invest in healthcare ...
Pharma and biotech companies have access to an unprecedented variety of health data, from electronic health records and ...
China Releases First Novel Drugs List for Commercial Insurance, With CAR-T Therapies Leading the Way
(Yicai) Dec. 8 -- China introduced its first Commercial Health Insurance Innovative Drug List that includes five chimeric ...
Ms. Ishak brings more than 25 years of corporate legal and strategic leadership experience in the life sciences industry ...
Partnership aims to produce clinical and commercial batches of ophthalmic formulation of SeaBeLife’s drug candidate to treat degenerative disorders of retina, with view to starting clinical trials in ...
Cynata is preparing for two trial readouts in 2026 in knee osteoarthritis and acute graft-versus-host disease.
Aging is being reframed as a biological process that can be measured and potentially altered. The longevity market is ...
ARMR Sciences of New York is trialing a vaccine in the Netherlands to protect against fentanyl-related overdose and death.
US FDA releases draft guidance on reducing testing on non-human primates for monoclonal antibodies: Silver Spring, Maryland Thursday, December 4, 2025, 09:00 Hrs [IST] The US Food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback